Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells

Abstract

RIZ1 is a tumor suppressor gene. The purpose of the present study was to investigate the inhibitory effect of RIZ1 gene therapy on the growth of SiHa cervical cancer cells and its synergism with paclitaxel. The expression levels of RIZ1 were examined by real-time PCR and western blotting before and after transfection of RIZ1. The effects of paclitaxel or pcDNA3.1(+)-RIZ1 alone or in combination, on the proliferation of SiHa cells were evaluated by MTT method. The inhibitory effect on the proliferation of SiHa cells was more significant in the pcDNA3.1(+)-RIZ1 combined with paclitaxel group than in the pcDNA3.1(+)-RIZ1 or paclitaxel groups (P<0.05). The expression level of RIZ1 in SiHa cells increased after treatment with paclitaxel, which indicated a synergism between them. RIZ1 gene therapy combined with paclitaxel showed stronger cell inhibition than paclitaxel alone, which indicated a synergism between them.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Cinghu S, Anandharaj A, Lee HC, Yu JR, Park WY . FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer. J Cell Physiol 2011; 226: 1564–1572.

    Article  CAS  PubMed  Google Scholar 

  2. Wang X, Shen Y, Zhao Y, Li Z, Gou H, Cao D et al. Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: a phase II trial. Eur J Surg Oncol 2015; 41: 1082–1088.

    Article  PubMed  Google Scholar 

  3. Buda A, Lissoni AA, Floriani I, Biagioli E, Gerardi C, Bonazzi C et al. Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: validity of pathological response as surrogate endpoint of survival. Int J Gynecol Cancer 2015; 25: 1468–1475.

    Article  PubMed  Google Scholar 

  4. Micha JP, Sassoon AF, Wong H, Goldstein BH . Prolonged remission of recurrent cervical carcinoma following paclitaxel and carboplatin chemotherapy with paclitaxel maintenance chemotherapy. Anticancer Drugs 2015; 26: 793–796.

    Article  CAS  PubMed  Google Scholar 

  5. Khongkow P, Gomes AR, Gong C, Man EP, Tsang JW, Zhao F et al. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene 2016; 35: 990–1002.

    Article  CAS  PubMed  Google Scholar 

  6. Shen Y, Wang P, Li Y, Ye F, Wang F, Wan X et al. miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer. Br J Cancer 2013; 109: 92–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Buyse IM, Shao G, Huang S . The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci USA 1995; 92: 4467–4471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Liu L, Shao G, Steele-Perkins G, Huang S . The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem 1997; 272: 2984–2991.

    Article  CAS  PubMed  Google Scholar 

  9. Derunes C, Briknarova K, Geng L, Li S, Gessner CR, Hewitt K et al. Characterization of the PR domain of RIZ1 histone methyltransferase. Biochem Biophys Res Commun 2005; 333: 925–934.

    Article  CAS  PubMed  Google Scholar 

  10. Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 2001; 15: 2250–2262.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Liu ZY, Wang JY, Liu HH, Ma XM, Wang CL, Zhang XP et al. Retinoblastoma protein-interacting zinc-finger gene 1 (RIZ1) dysregulation in human malignant meningiomas. Oncogene 2013; 32: 1216–1222.

    Article  CAS  PubMed  Google Scholar 

  12. Dong S, Zhang P, Liang S, Wang S, Sun P, Wang Y . The role of the retinoblastoma protein-interacting zinc finger gene 1 tumor suppressor gene in human esophageal squamous cell carcinoma cells. Oncol Lett 2013; 6: 1656–1662.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dong SW, Li D, Xu C, Sun P, Wang YG, Zhang P . Alteration in gene expression profile and oncogenicity of esophageal squamous cell carcinoma by RIZ1 upregulation. World J Gastroenterol 2013; 19: 6170–6177.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Congdon LM, Sims JK, Tuzon CT, Rice JC . The PR-Set7 binding domain of Riz1 is required for the H4K20me1-H3K9me1 trans-tail 'histone code' and Riz1 tumor suppressor function. Nucleic Acids Res 2014; 42: 3580–3589.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Braig M, Schmitt CA . Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res 2006; 66: 2881–2884.

    Article  CAS  PubMed  Google Scholar 

  16. Lal G, Padmanabha L, Smith BJ, Nicholson RM, Howe JR, O'Dorisio MS et al.: RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma. Cancer 2006; 107: 2752–2759.

    Article  CAS  PubMed  Google Scholar 

  17. Akahira J, Suzuki F, Suzuki T, Miura I, Kamogawa N, Miki Y et al. Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation. Pathol Int 2007; 57: 725–733.

    Article  CAS  PubMed  Google Scholar 

  18. Hasegawa Y, Matsubara A, Teishima J, Seki M, Mita K, Usui T et al. DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci 2007; 98: 32–36.

    Article  CAS  PubMed  Google Scholar 

  19. Tam W, Gomez MF, Chadburn A, Knowles DM, Houldsworth J . Lack of A563G (I188V) missense mutation in RIZ/ PRDM2 in human diffuse large B-cell lymphomas. Genes Chromosomes Cancer 2007; 46: 416–418.

    Article  CAS  PubMed  Google Scholar 

  20. Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B et al. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res 2006; 312: 340–349.

    CAS  PubMed  Google Scholar 

  21. Dong SW, Cui YT, Zhong RR, Liang DC, Liu YM, Wang YG et al. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation. Clin Lab 2012; 58: 41–51.

    CAS  PubMed  Google Scholar 

  22. Jiang GL, Huang S . Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Cancer Res 2001; 61: 1796–1798.

    CAS  PubMed  Google Scholar 

  23. Dong SW, Zhang P, Liu YM, Cui YT, Wang S, Liang SJ et al. Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma. World J Gastroenterol 2012; 18: 576–582.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Zhang C, Li H, Wang Y, Liu W, Zhang Q, Zhang T et al. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. J Hepatol 2010; 53: 889–895.

    Article  CAS  PubMed  Google Scholar 

  25. Mori N, Yoshinaga K, Tomita K, Ohwashi M, Kondoh T, Shimura H et al. Aberrant methylation of the RIZ1 gene in myelodysplastic syndrome and acute myeloid leukemia. Leuk Res 2011; 35: 516–521.

    Article  CAS  PubMed  Google Scholar 

  26. Piao GH, Piao WH, He Y, Zhang HH, Wang GQ, Piao Z . Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma. Histol Histopathol 2008; 23: 1171–1175.

    CAS  PubMed  Google Scholar 

  27. Kobayashi Y, Umemoto T, Takeshita Y, Kohyama N, Ohbayashi M, Sanada Y et al. Functional characterization and substrate specificity of a novel gene encoding zinc finger-like protein, ZfLp, in Xenopus laevis oocytes. J Toxicol Sci 2012; 37: 699–709.

    Article  CAS  PubMed  Google Scholar 

  28. Zeimet AG, Riha K, Berger J, Widschwendter M, Hermann M, Daxenbichler G et al. New insights into p53 regulation and gene therapy for cancer. Biochem Pharmacol 2000; 60: 1153–1163.

    Article  CAS  PubMed  Google Scholar 

  29. Huh WK, Gomez-Navarro J, Arafat WO, Xiang J, Mahasreshti PJ, Alvarez RD et al. Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix. Gynecol Oncol 2001; 83: 370–377.

    Article  CAS  PubMed  Google Scholar 

  30. Roz L, Gramegna M, Ishii H, Croce CM, Sozzi G . Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proc Natl Acad Sci USA 2002; 99: 3615–3620.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Minaguchi T, Mori T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y et al. Growth suppression of human ovarian cancer cells by adenovirus-mediated transfer of the PTEN gene. Cancer Res 1999; 59: 6063–6067.

    CAS  PubMed  Google Scholar 

  32. Cheng HY, Gao Y, Lou G . DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer. Eur J Med Res 2010; 15: 20–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Khaenam P, Niibori A, Okada S, Jearanaikoon P, Araki N, Limpaiboon T . Contribution of RIZ1 to regulation of proliferation and migration of a liver fluke-related cholangiocarcinoma cell. Asian Pac J Cancer Prev 2012; 13: 4007–4011.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Donglin Sun for her excellent technical assistance. This work was supported by the science and technology research project of Heilongjiang province education department (No. 12521191).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Cheng.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cheng, H., Zhang, T., Qu, Y. et al. Synergism between RIZ1 gene therapy and paclitaxel in SiHa cervical cancer cells. Cancer Gene Ther 23, 392–395 (2016). https://doi.org/10.1038/cgt.2016.44

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2016.44

This article is cited by

Search

Quick links